Douglas M Cromeens

Title: The Innovative Contributions of Douglas M Cromeens

Introduction

Douglas M Cromeens is a notable inventor based in Spring, Texas. He has made significant contributions to the field of medical research, particularly in understanding opportunistic mold infections. His work has implications for the development of antifungal agents and early detection technologies.

Latest Patents

Cromeens holds a patent for a "Large animal model of invasive pulmonary aspergillosis in an immunocompromised host." This invention establishes a model of systemic mold infection in a profoundly immunocompromised beagle dog. The model was created by rendering the beagle immunosuppressed through total body irradiation and daily steroids. This allowed for the successful inoculation of mold through a bronchoscope, leading to a localized infection that spread throughout the lung parenchyma, ultimately resulting in the animal's death. The invention aims to further study the pathophysiology of opportunistic mold infections in vivo and provides a foundation for developing new antifungal agents and detection technologies.

Career Highlights

Cromeens is affiliated with the University of Texas System, where he conducts his research. His work is pivotal in advancing the understanding of mold infections and their treatment. The insights gained from his research are expected to improve patient outcomes and reduce the need for clinical trials that may not yield effective results.

Collaborations

Cromeens has collaborated with notable colleagues, including Borje S Andersson and Taraneh K Sadeghi. Their combined expertise enhances the research efforts and broadens the impact of their findings in the medical community.

Conclusion

Douglas M Cromeens is a distinguished inventor whose work in developing a large animal model for studying invasive pulmonary aspergillosis has significant implications for medical research. His contributions are expected to lead to advancements in antifungal treatments and early detection methods, ultimately benefiting patient care.